荒井啓行（東北大学・医学部附属病院）

1.Okamura N, Arai H, Maruyama M, Higuchi M, Matsui T, Tanji H, Seki T, Hirai H, Chiba H, Itoh M, Sasaki H: Combined analysis of CSF-tau and [¹²³I]Iodoamphetamine-SPECT in mild cognitive impairment: Implications for a novel predictor of Alzheimer’s disease. Am J Psychiat 159: 474-476, 2002

2.Matsushita S, Arai H, Okamura N, Ohmori T, Takasugi K, Matsui T, Maruyama M, Iwatsubo T, Higuchi S: Clinical and bio-marker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild impairment stage of Alzheimer’s disease. Biol Psychiat 52: 907-1910, 2002

3.Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttila T, Schapiro MB, Rapoport SI, Möller H-J, Davies P, Hampel H: Differential diagnosis of Alzheimer's disease with CSF tau proteinphosphorylated at threonine 231. Arch Neurol 59: 1267-1272, 2002

4.Ebihara T, Yamaya M, Ohrui T, Arai H, Sasaki H: Comparison of disabled older people in the USA and Japan. Geriatr Gerontol Int 2: 53-56, 2002

5.Ohrui T, Arai H, Ichinose M, Matsui T, Yamaya M, Sasaki H: Relationship between asthma severity and progression of Alzheimer’s disease. Thorax 57: 561, 2002

6.Matsui T, Yamaya M, Ohrui T, Arai H, Sasaki H: Sitting position to prevent aspiration in bed-ridden patients. Gerontology 48: 194-195, 2002

7.Buerger K, Zinkowski R, Teipel SJ, Arai H: Differentiation between geriatric major depression and Alzheimer’s disease with CSF tau protein phosphorylated at threonine 231. Am J Psychiat in press

8.Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Fujii T, Komemushi S, Itoh M, Sasaki H, Watanabe T, Yanai K: Differential cognitive effects of ebastine and (+)-chorphenilamine in healthy subjects: correlation between cognitive impairment and plasma drug concentrations. Br J Clin Pharmacol 53: 296-304, 2002

9.Hu X, Okamura N, Arai H, Higuchi M, Maruyama M, Itoh M, Yamaguchi K, Sasaki H: Neuroanatomical correlates of low body weight in Alzheimer’s disease. Prog Neuro-psychopharmacol Biol Psychiat 26: 1285-1289, 2002

10.Buerger K, Teipel SJ, Zinkowski R, Blennow K, Arai H, Engel R, Hofman K: CSF-tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 59: 627-629, 2002

11.Li JQ, Jia YX, Yamaya M, Arai H, Ohrui T, Sekizawa T, Sasaki H: Neurochemical regulation of cough response to capsaicin in guinea-pig. Auton Autacoid Pharmacol 22: 57-63, 2002

12.Ohara S, Tsuyuzaki J, Oide T, Arai H, Higuchi S, Hasegawa M, Iwatsubo T: A clinical and neuropathologcal study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration? Neurosci Lett 300: 84-88, 2002

13.Shinkawa M, Yamaya M, Ohrui T, Arai H, Sasaki H: Depression in older people. Geriatr Gerontol Internat 2: 215-216, 2002

14.Maruyama M, Arai H, Okamura N, Matsui M, Sasaki H: Biomarkers in subjects with amnestic mild cognitive impairment. J Am Geriatr Soc in press

15.Arai H, Matsui T, Okamura N, Maruyama M: CSF-tau in subjective memory complainers. Lancet in press

新井平伊（順天堂大学・医学部）

1.Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease. Neurosci Lett 323: 161-163, 2002

2.Yamaguchi M, Suzuki T, Abe S, Hori T, Kurita H, Asada T, Okado N, Arai H: Repeated cocaine administration differentially affects NMDA receptor subunit (NR1, NR2A-C) mRNAs in rat brain. Synapse 46: 157-69, 2002

3. Higashi H, Ohnuma T, Shibata N, Ishizuka T, Higashi M, Ohtuka E, Ueki A, Nagao M, Arai H: Association of transforming growth factor-a1 gene polymorphisms in Japanese sporadic Alzheimer’s disease. Alz Rep 5: 21-24, 2002

4.Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114: 436-439, 2002

植木　彰（自治医大・大宮医療センター）

1.Shibata N, Ohnuma T, Takahasi T, Baba H, Ishizuka T, Otsuka M, Ueki A, Nagao M, Arai H: The effect of IL4 +33C/T polymorphism on risk of Japanese sporadic Alzheimer's disease. Neurosci Lett 323: 161-163, 2002

2.Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114: 436-439, 2002

浦上克哉（鳥取大学・医学部）

1.Shoji M, Matsubara E, Murakami T, Manabe Y, Abe K, Kanai M, Ikeda M, Tomidokoro Y, Shizuka M, Watanabe M, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Nishimura T, Nakamura Y, Takeda M, Urakami K, Adachi Y, Nakashima K, Arai H, Sasaki H, Kanemaru K, Yamanouchi H, Yoshida Y, Ichise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Yoshida H, Toji H, Nakamura S, Hirai S: Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiol Aging 23: 363-370, 2002

2.Wakutani Y, Ito T, Wada-Isoe K, Yamagata K, Adachi Y, Taniguchi M, Arai H, Sasaki H, Higuchi S, Sato K, Urakami K, Nakashima K: Identification of aberrant tau mRNA in brain tissue. Alz Rep 4: 145-150, 2002

3.Wakutani Y, Kowa H, Kusumi M, Nakaso K, Yasui K, Isoe-Wada K, Yano H, Urakami K, Nakashima K: A protective haplotype of the methylenetetrahydrofolate reductase gene against late-onset Alzheimer’s disease. Neurobiol Aging in press

太田成男（日本医科大学・老人病研究所）

1.Nomiyama T, Tanaka Y, Hattori N, Nishimaki K, Nagasaka K, Kawamori R, Ohta S: Accumulation of somatic mutation in mitochondrial DNA extracted from peripheral blood cells in diabetic patients. Diabetologia 45: 1577-1583, 2002

2.Yamada Y, Ando F, Niino N, Ohta S, Shimokata H: Association of polymorphisms of the estrogen receptorαgene with bone mineral density of the femoral neck in elderly Japanese women. J Mol Med 80: 452-460, 2002

3.Harada H, Nagai H, Ezura Y, Yokota T, Ohsawa I, Yamaguchi K, Ohue C, Tsuneizumi M, Mikami I, Terada Y, Yabe A, Emi M: Down-regulation of a novel gene, DRLM, in human liver malignancy from 4q22 that encodes a NAP-like protein. Gene 296: 171-177, 2002

4.Nakano K, Tanabe M, Nakagawa S, Ohta S, Matuda S: Isolation and sequence analysis of the rat dihydrolipoamide succinyltransferase gene. DNA Seq 13: 363-367, 2002

5.Suzuki Y, Taniyama M, Muramatsu T, Ohta S, Atsumi Y, Matsuoka K: Influence of alcohol intake and aldehyde dehydrogenase 2 phenotype on peripheral neuropathy of diabetes. Diabetes Care 26: 249, 2003

6.Suzuki Y, Taniyama M, Muramatsu T, Ohta S, Atsumi Y, Matsuoka K: Diabetic vasculopathy and alcohol tolerance trait in type 2 diabetes. Diabetes Care 26: 246-247, 2003

7.Ohsawa I, Nishimaki K, Yasuda C, Kamino K, Ohta S: Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J Neurochem 84: 1110-1117, 2003

8.Yasukawa T, Suzuki T, Ohta S, Watanabe K: Wobble modification defect suppresses translational activity of tRNAs with MERRF and MELAS mutations. Mitochondrion in press

9.Suzuki Y, Kuriyama S, Taniyama M, Muramatsu T, Ohta S, AtsumiY, Murata C, Matsuoka K: Maternal inheritance of diabetes is associated with inactive ALDH2 genotype in diabetics with renal failure in Japanese. Diabetes Res Clin Pr in press

10.Suzuki Y, Matsuura N, Suzuki S, Muramatsu T, Taniyama M, Ohta S, Higuchi S, Tsukahara M, Atsumi Y, Matsuoka K: Aldehyde dehydrogenase 2 genotype in type 1 diabetes mellitus. Diabetes Res Clin Pr in press

川又敏男（神戸大学・医学部）

1.Tanimukai S, Hasegawa H, Nakai M, Yagi K, Hirai M, Saito N, Taniguchi T, Terashima A, Yasuda M, Kawamata T, Tanaka C: Nanomolar amyloid ß protein activates a specific PKC isoform mediating phosphorylation of MARCKS in Neuro2A cells. Neuroreport 13: 549-553, 2002

下方浩史（国立療養所中部病院・長寿医療研究センター）

1.Kuzuya M, Ando F, Iguchi A, Shimokata H: Changes in serum lipid levels during a 10-year period in a large Japanese population: A cross-sectional and longitudinal study. Atherosclerosis 163: 313-320, 2002

2.Kajioka T, Tsuzuku S, Shimokata H, Sato Y: Effects of intentional weight cycling in non-obese young women. Metabolism 51: 149-154, 2002

3.Iwao S, Iwao N, Muller DC, Elahi D, Shimokata H, Andres R: Does waist circumference add to the predictive power of the body mass index for coronary risk? Obes Res 9: 685-695, 2001

4.Yamada Y, Ando F, Niino N, Shimokata H: Association of a polymorphism of the matrix metalloproteinase-1 gene with bone mineral density. Matrix Biol 21: 389, 2002

5.Yamada Y, Ando F, Niino N, Shimokata H: Association of a polymorphism of the CC chemokine receptor 2 gene with bone mineral density. Genomics 80: 8-12, 2002

6.Yamada Y, Ando F, Niino N, Shimokata H: Association of polymorphisms of the estrogen receptor a gene with bone mineral density in elderly Japanese women. J Mol Med 80: 452-460, 2002

7.Yamada Y, Fujisawa M, Ando F, Niino N, Tanaka M, Shimokata H: Association of a polymorphism of the transforming growth factor-ß1 gene with blood pressure in Japanese. J Hum Genet 47: 243-248, 2002

8.Okura T, Tanaka K, Nakanishi T, Don JL, Nakata Y, Seung WW, Shimokata H: Effect of obesity phenotype on the improvement of CHD risk factors in response to weight loss. Obes Res 10: 757-766, 2002

9.Nomura H, Ando F, Niino N, Shimokata H, Miyake Y: The relationship between age and intraocular pressure in a Japanese population: The influence of central corneal thickness. Curr Eye Res 24: 81-85, 2002

10.Kuzuya M, Ando F, Iguchi A, Shimokata H.: Effect of aging on serum uric acid levels: longitudinal changes in a large Japanese population group. J Gerontol 57: M660-664, 2002

11.Shimizu N, Nomura H, Ando F, Niino N, Miyake Y, Shimokata H: Refractive errors and associating factors with myopia in adult Japanese population. Jpn J Ophthalmol 47: 6-12, 2003

12.Takekuma K, Ando F, Niino N, Shimokata H: Prevalence of hyperesthesia detected by current perception threshold test in subjects with glucose metabolic impairment in a community. Int Med 41: 1124-1129, 2002

13.Okura T, Koda M, Ando F, Niino N, Shimokata H: Relationship of resting energy expenditure with body fat distribution and abdominal fatness in Japanese population. J Physiol Anthropol 22: 47-52, 2003

東海林幹夫（岡山大学・大学院医歯学総合研究科）

1.Shoji M, Matsubara E, Murakami T, Manabe Y, Abe K, Kanai M, Ikeda M, Tomidokoro Y, Shizuka M, Watanabe M, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Nishimura T, Nakamura Y, Takeda M, Urakami K, Adachi Y, Nakashima K, Arai H, Sasaki H, Kanemaru K, Yamanouchi H, Yoshida Y, Ichise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Yoshida H, Toji H, Nakamura S, Hirai S: Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiol Aging 23: 363-70, 2002

2.Shoji M, Fukushima K, Wakayama M, Shizuka-Ikeda M, Ikeda Y, Kawakami A, Sakazume Y, Ikeda M, Harigaya Y, Matsubara E, Kawarabayashi T, Murakami T, Nagano I, Manabe Y, Abe K: Intellectual faculities in patients with Alzheimer’s disease regress to the level of a 4-5-year old child. Geriatr Gerontol Internat 2: 143-147, 2002

3.Shizuka-Ikeda M, Matsubara E, Ikeda M, Kanai M, Tomidokoro Y, Ikeda Y, Watanabe M, Kawarabayashi T, Harigaya Y, Okamoto K, Maruyama K, Castano EM, St George-Hyslop P, Shoji M: Generation of amyloid ß protein from a presenilin-1 and ßAPP complex. Biochem Biophys Res Commun 292: 571-578, 2002

4.Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, Younkin LH, Younkin SG, Golde TE: Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9: 11-23, 2002

5.Matsubara E, Bryant-Thomas T, Pacheco J, Henry TL, Poeggeler B, Manjon M, Herbert D, Cruz-Sanchez  F, Chyan Y-J, Shoji M, Abe K, Leone A, Grundke-Iqbal I, Wilson G,  Ghiso J, Williams C, Refolo LM, Pappolla MA: Melatonin Increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J Neurochem in press

6.Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y: Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch 441: 358-367, 2002

7.Prat MI, Adamo AM, Gonzalez SA, Affranchino JL, Ikeda M, Matsubara E, Shoji M, Smith MA, Castano EM, Morelli L: Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration. Neurosci Lett 326: 9-12, 2002

8.Sato K, Iwai M, Nagano I, Shoji M, Abe K: Temporal and spacial changes of highly polysialylated neural cell adhesion molecule immunoreactivity in amygdala kindling development. Neurol Res 25: 79-82, 2003

9.Li F, Omori N, Jin G, Wang SJ, Sato K, Nagano I, Shoji M, Abe K: Cooperative expression of survival p-ERK and p-Akt signals in rat brain neurons after transient MCAO. Brain Res 962: 21-26, 2003

10.Ohta K, Iwai M, Sato K, Omori N, Nagano I, Shoji M, Abe K: Dissociative increase of oligodendrocyte progenitor cells between young and aged rats after transient cerebral ischemia. Neurosci Lett 335: 159-62, 2003

11.Kamada H, Sato K, Iwai M, Zhang WR, Nagano I, Manabe Y, Shoji M, Abe K: Temporal and spatial changes of free cholesterol and neutral lipids in rat brain after transient middle cerebral artery occlusion. Neurosci Res 45: 91-100, 2003

12.Jin G, Omori N, Li F, Sato K, Nagano I, Manabe Y, Shoji M, Abe K: Activation of cell-survival signal Akt by GDNF in normal rat brain. Brain Res 958: 429-433, 2002

13.Li F, Omori N, Sato K, Jin G, Nagano I, Manabe Y, Shoji M, Abe K: Coordinate expression of survival p-ERK and proapoptotic cytochrome c signals in rat brain neurons after transient MCAO. Brain Res 958: 83-88, 2002

14.Omori N, Jin G, Li F, Zhang WR, Wang SJ, Hamakawa Y, Nagano I, Manabe Y, Shoji M, Abe K: Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain Res 954: 317-322, 2002

15.Wang SJ, Omori N, Li F, Zhang WR, Jin G, Hamakawa Y, Sato K, Nagano I, Shoji M, Abe K: Enhanced expression of phospho-Akt by electro-acupuncture in normal rat brain. Neurol Res 24: 719-724, 2002

16.Ohta Y, Manabe Y, Sasaki C, Shiote M, Hayashi T, Shoji M, Abe K: A case of paroxysmal kinesigenic dyskinesia with spastic paraparesis. Neurol Res 24: 684-686, 2002

17.Sato K, Murakami T, Hamakawa Y, Kamada H, Nagano I, Shoji M, Takata H, Nobukuni K, Ihara Y, Namba R, Hayabara T, Hirose S, Abe K: Selective colocalization of transglutaminase-like activity in ubiquitinated intranuclear inclusions of hereditary dentatorubral-pallidoluysian atrophy. Brain Res 952: 327-330, 2002

18.Wang SJ, Omori N, Li F, Jin G, Zhang WR, Hamakawa Y, Sato K, Nagano I, Shoji M, Abe K: Potentiation of Akt and suppression of caspase-9 activations by electroacupuncture after transient middle cerebral artery occlusion in rats. Neurosci Lett 331: 115-118, 2002

19.Sato K, Iwai M, Nagano I, Shoji M, Abe K: Temporal and spacial changes of BrdU immunoreactivity in amygdala kindling development. Neurol Res 24: 593-596, 2002

20.Warita H, Manabe Y, Murakami T, Shiote M, Shiro Y, Hayashi T, Nagano I, Shoji M, Abe K: Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurol Res 24: 577-581, 2002

21.Sato K, Iwai M, Nagano I, Shoji M, Abe K: Changes of localization of highly polysialylated neural cell adhesion molecule (PSA-NCAM) in rat hippocampus with exposure to repeated kindled seizures. Brain Res 946: 323-327, 2002

22.Ohta Y, Hayashi T, Sasaki C, Shiote M, Manabe Y, Shoji M, Abe K: Cauda equina syndrome caused by idiopathic sacral epidural lipomatosis. Intern Med 41: 593-594, 2002

23.Manabe Y, Nagano I, Gazi MS, Murakami T, Shiote M, Shoji M, Kitagawa H, Setoguchi Y, Abe K: Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis. Apoptosis 7: 329-334, 2002

24.Manabe Y, Warita H, Murakami T, Shiote M, Hayashi T, Omori N, Nagano I, Shoji M, Abe K: Early decrease of the immunophilin FKBP 52 in the spinal cord of a transgenic model for amyotrophic lateral sclerosis. Brain Res 935: 124-128, 2002

25.Manabe Y, Narai H, Warita H, Hayashi T, Shiro Y, Sakai K, Kashihara K, Shoji M, Abe K: Benign adult familial myoclonic epilepsy (BAFME) with night blindness. Seizure 11: 266-8, 2002

26.Sato K, Iwai M, Nagano I, Shoji M, Abe K: Expression of highly polysialylated neural cell adhesion molecule in rat subventricular zone with exposure to repeated kindled seizures. Neurosci Lett 323: 244-246, 2002

27.Iwai M, Sato K, Omori N, Nagano I, Manabe Y, Shoji M, Abe K: Three steps of neural stem cells development in gerbil dentate gyrus after transient ischemia. J Cereb Blood Flow Metab 22: 411-419, 2002

南光進一郎（帝京大学・医学部）

1.Kunugi H, Kato T, Fukuda R, Tatsumi M, Sakai T, Nanko S: Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders. J Neural Transm 109: 213-218, 2002

2.Hattori M, Kunugi H, Akahane A, Tanaka H, Ishida S, Hirose T, Morita R, Yamakawa K, Nanko S: Novel polymorphisms in the promoter region of the neurotrophin-3 gene and their associations with schizophrenia. Am J Med Genet 114: 304-309, 2002

3.Hata T, Kunugi H, Nanko S, Fukuda R, Kaminaga T: Possible effect of the APOE ε4 allele on the hippocampal volume and asymmetry in schizophrenia. Am J Med Genet 114: 641-642, 2002

4.Akahane A, Kunugi H, Tanaka H, Nanko S: Association analysis of polymorphic CGG repeat in 5' UTR of the reelin and VLDLR genes with schizophrenia. Schizophr Res 58: 37-41, 2002

5.Kato T, Iwamoto K, Washizuka S, Mori K, Tajima O, Akiyama T, Nanko S, Kunugi H, Kato N: No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans. Neurosci Lett 338: 21-24, 2003

6.Kunugi H, Hirasawa H, Kato N, Nabika T, Kobayashi S, Nanko S: Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr Res in press

前田　潔（神戸大学・大学院医学系研究科）

1.Nishiguchi N, Shirakawa O, Ono H, Nishimura A, Nushida H, Ueno Y, Maeda K: Lack of an association between 5HT1A receptor gene structural polymorphisms and suicide victims. Am J Med Genet 114: 423-425, 2002

2.Lin XH, Hashimoto T, Kitamura N, Murakami N, Shirakawa O, Maeda K: Decreased calcineurin and increased phosphothreonine-DARPP-32 in the striatum of rats behaviorally sensitized to methamphetamine. Synapse 44: 181-187, 2002

3.Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K: No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet 114: 340-342, 2002

4.Ono H, Shirakawa O, Kitamura N, Hashimoto T, Nishiguchi N, Nishimura A, Nushida H, Ueno Y, Maeda K: Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol Psychiat 7: 1127-1132, 2002

5.Yanagihara C, Yasuda M, Maeda K, Miyoshi K, Nishimura Y: Rapidly progressive dementia syndrome associated with a novel four extra repeat mutation in the prion protein gene. J Neurol Neurosurg Psychiat 72: 788-791, 2002

6.Toyooka K, Iritani S, Makifuchi T, Shirakawa O, Kitamura N, Maeda K, Nakamura R, Niizato K, Watanabe M, Kakita A, Takahashi H, Someya T, Nawa H: Selective reduction of a PDZ protein, SAP-97, in the prefrontal cortex of patients with chronic schizophrenia. J Neurochem 83: 797-806, 2002

7.Aoyama S, Shirakawa O, Ono H, Hashimoto T, Kajimoto Y, Maeda K: A novel polymorphism in the coding region of the DAP-1 gene (hDLG and PSD-95 associated protein-1 gene): analysis of association with schizophrenia. Psychiat Clin Neurosci in press